Home » Mylan Confirms First-to-File Patent Challenge Relating to Nuvigil
Mylan Confirms First-to-File Patent Challenge Relating to Nuvigil
Mylan Inc. Monday confirmed that it was sued by Cephalon Inc. and Cephalon
France in connection with the filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Armodafinil Tablets, 50 mg,
150 mg and 250 mg.
GEN
GEN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May